Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul 2;56(1):2001190.
doi: 10.1183/13993003.01190-2020. Print 2020 Jul.

Risk factors for viral RNA shedding in COVID-19 patients

Affiliations

Risk factors for viral RNA shedding in COVID-19 patients

Yu Fu et al. Eur Respir J. .

Abstract

The median time of SARS-CoV-2 viral RNA shedding was 19 days. Patients with coronary heart disease comorbidity or decreased albumin levels experienced delays in clearance of SARS-CoV-2 RNA. https://bit.ly/2zjQu64

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: Y. Fu has nothing to disclose. Conflict of interest: P. Han has nothing to disclose. Conflict of interest: R. Zhu has nothing to disclose. Conflict of interest: T. Bai has nothing to disclose. Conflict of interest: J. Yi has nothing to disclose. Conflict of interest: X. Zhao has nothing to disclose. Conflict of interest: M. Tao has nothing to disclose. Conflict of interest: R. Quan has nothing to disclose. Conflict of interest: C. Chen has nothing to disclose. Conflict of interest: Y. Zhang has nothing to disclose. Conflict of interest: Q. He has nothing to disclose. Conflict of interest: M. Jing has nothing to disclose. Conflict of interest: X. Xiong has nothing to disclose. Conflict of interest: D. Tian has nothing to disclose. Conflict of interest: W. Yan has nothing to disclose.

Figures

FIGURE 1
FIGURE 1
Kaplan–Meier curves showing the proportions of SARS-CoV-2 RNA-positive patients. T1 refers to the duration from the symptom onset to the day when SARS-CoV-2 RNA was negative for two consecutive times, which was considered to indicate an undetectable viral RNA level. a) All patients (n=410). b) Patients with (n=27) and without (n=383) coronary heart disease; p=0.029. c) Patients with albumin levels <35 g·L−1 (n=193) and ≥35 g·L−1 (n=217); p=0.032. d) Patients who started antiviral therapy >7 days (n=128) and ≤7 days (n=278) after symptom onset; p<0.001.

References

    1. World Health Organization Coronavirus disease (COVID-19) outbreak situation. www.who.int/emergencies/diseases/novel-coronavirus-2019 Date last accessed: 25 April 2020.
    1. World Health Organization WHO Director-General's opening remarks at the media briefing on COVID-19 – 11 March 2020. www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at... Date last updated: 11 March 2020. Date last accessed: 25 April 2020.
    1. National Health Commission of the People's Republic of China Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7) www.gov.cn/zhengce/zhengceku/2020-03/04/content_5486705.htm Date last updated: 3 March 2020. Date last accessed: 25 April 2020.
    1. Zhou F, Yu T, Du R, et al. . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395: 1054–1062. doi:10.1016/S0140-6736(20)30566-3 - DOI - PMC - PubMed
    1. Dziedzic T, Pera J, Klimkowicz A, et al. . Serum albumin level and nosocomial pneumonia in stroke patients. Eur J Neurol 2006; 13: 299–301. doi:10.1111/j.1468-1331.2006.01210.x - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources